Description
This product utilizes γδ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO26). We employs the Retrovirus (p15A-Cy3-IRF-SmaI) vector components and the SynExpress system of the histone modification sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO26
Species Reactivity
Human
Cell Source
γδ T cells
Sensor Gene
Cy3
Promoter
p15A
Effector Gene
IRF
Insertion Sites
SmaI
Gene Modification
Knock-in
Modification Domain
Histone modification sites
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.